4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Chen Wei, Hu Zhiliang, Yi Changhua, Chi Yun, Xiong Qingfang, Tan Chee Wah, Yi Yongxiang, Wang Lin-Fa. An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report[J]. The Journal of Biomedical Research, 2020, 34(6): 470-474. DOI: 10.7555/JBR.34.20200099
Citation: Chen Wei, Hu Zhiliang, Yi Changhua, Chi Yun, Xiong Qingfang, Tan Chee Wah, Yi Yongxiang, Wang Lin-Fa. An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report[J]. The Journal of Biomedical Research, 2020, 34(6): 470-474. DOI: 10.7555/JBR.34.20200099

An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report

More Information
  • Corresponding author:

    Yongxiang Yi, Nanjing infectious Disease Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, 1-1 Zhongfu Road, Nanjing, Jiangsu 210003, China. Tel: +86-25-83626203, E-mail: yongxiangyinj@163.com

    Lin-Fa Wang, Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore. E-mail: linfa.wang@duke-nus.edu.sg

  • Received Date: June 21, 2020
  • Revised Date: July 19, 2020
  • Accepted Date: July 21, 2020
  • Available Online: September 15, 2020
  • The ongoing coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis, causing social and economic disasters in many countries. In China, two-consecutive negative results of nucleic acid tests for SARS-CoV-2 from the respiratory samples are required to end the quarantine of COVID-19 patients. However, clinicians face a dilemma in case of patients with long-term viral shedding. This report described an unusual COVID-19 case who had persistent viral RNA positivity for more than 4 months after initial illness in the presence of low neutralizing antibodies, but without prolonged clinical symptoms. Multiple anti-viral drug treatments had no impact and there was no evidence of re-infection. When the patient was self-quarantined at home, no infection occurred to the three family members living with her for 15 to 19 days. Sputum viral culture in BSL-3 laboratory on the 102nd day after symptom onset was negative. From the 129th day on, 8 continuous nucleic acid tests of sputum samples showed negative results. The patient was discharged on 137th days since symptom onset. In conclusion, viral RNA shedding in the sputum of the COVID-19 patient may last over 4 months. As no evidence shows the existence of infectious virus, two-consecutive negative nucleic acid tests may not be the prerequisite for ending quarantine of COVID-19 patients with prolonged viral shedding.
  • [1]
    National Health Commission, National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7)[J]. Chin Med J, 2020, 133(9): 1087–1095. doi: 10.1097/CM9.0000000000000819
    [2]
    Lu RJ, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224): 565–574. doi: 10.1016/S0140-6736(20)30251-8
    [3]
    Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test (sVNT) based on antibody-mediated blockage of ACE2-spike (RBD) protein-protein interaction[J]. Nat Biotechnol, 2020, 38(9): 1073–1078. doi: 10.1038/s41587-020-0631-z
    [4]
    He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19[J]. Nat Med, 2020, 26(5): 672–675. doi: 10.1038/s41591-020-0869-5
    [5]
    Qi L, Yang Y, Jiang DX, et al. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study[J]. Int J Infect Dis, 2020, 96: 531–537. doi: 10.1016/j.ijid.2020.05.045
    [6]
    Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019[J]. Nature, 2020, 581(7809): 465–469. doi: 10.1038/s41586-020-2196-x
    [7]
    Zhou F, Yu T, Du RH, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395(10229): 1054–1062. doi: 10.1016/S0140-6736(20)30566-3
    [8]
    Liu WD, Chang SY, Wang JT, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19[J]. J Infect, 2020, 81(2): 318–356. doi: 10.1016/j.jinf.2020.03.063
    [9]
    Gasparyan AY, Misra DP, Yessirkepov M, et al. Perspectives of immune therapy in coronavirus disease 2019[J]. J Korean Med Sci, 2020, 35(18): e176. doi: 10.3346/jkms.2020.35.e176
    [10]
    Shen CG, Wang ZQ, Zhao F, et al. Treatment of 5 Critically Ill patients with COVID-19 with convalescent plasma[J]. JAMA, 2020, 323(16): 1582–1589. doi: 10.1001/jama.2020.4783
  • Related Articles

    [1]Ya Xie, Zifeng Xu, Yumin Zhang, Yisheng Li, Pengyu Du, Chun Wang. First-episode psychiatric disorder risk from SARS-CoV-2 infection: A clinical analysis with Chinese psychiatric inpatients[J]. The Journal of Biomedical Research, 2025, 39(1): 50-60. DOI: 10.7555/JBR.38.20240005
    [2]Zheyue Wang, Qi Tang, Bende Liu, Wenqing Zhang, Yufeng Chen, Ningfei Ji, Yan Peng, Xiaohui Yang, Daixun Cui, Weiyu Kong, Xiaojun Tang, Tingting Yang, Mingshun Zhang, Xinxia Chang, Jin Zhu, Mao Huang, Zhenqing Feng. A SARS-CoV-2 neutralizing antibody discovery by single cell sequencing and molecular modeling[J]. The Journal of Biomedical Research, 2023, 37(3): 166-178. DOI: 10.7555/JBR.36.20220221
    [3]Jiao Chen, Can Zhao, Yingzi Huang, Hao Wang, Xiang Lu, Wei Zhao, Wei Gao. Malnutrition predicts poor outcomes in diabetic COVID-19 patients in Huangshi, Hubei[J]. The Journal of Biomedical Research, 2022, 36(1): 32-38. DOI: 10.7555/JBR.35.20210083
    [4]Liu Zhi, Wang Jianwei, Ge Yiyue, Xu Yuyu, Guo Mengchen, Mi Kai, Xu Rui, Pei Yang, Zhang Qiankun, Luan Xiaoting, Hu Zhibin, Chi Ying, Liu Xingyin. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response[J]. The Journal of Biomedical Research, 2021, 35(3): 216-227. DOI: 10.7555/JBR.35.20200154
    [5]Zhang Lei, McLeod Stephanie T., Vargas Rodolfo, Liu Xiaojian, Young Dorthy K., Dobbs Thomas E.. Subgroup comparison of COVID-19 case and mortality with associated factors in Mississippi: findings from analysis of the first four months of public data[J]. The Journal of Biomedical Research, 2020, 34(6): 446-457. DOI: 10.7555/JBR.34.20200135
    [6]Gorzalski Andrew J., Hartley Paul, Laverdure Chris, Kerwin Heather, Tillett Richard, Verma Subhash, Rossetto Cyprian, Morzunov Sergey, Van Hooser Stephanie, Pandori Mark W.. Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19[J]. The Journal of Biomedical Research, 2020, 34(6): 431-436. DOI: 10.7555/JBR.34.20200110
    [7]Mehta Neha, Qiao Renli. Medical management of COVID-19 clinic[J]. The Journal of Biomedical Research, 2020, 34(6): 416-421. DOI: 10.7555/JBR.34.20200118
    [8]Liu Shuying, Lu Shan. Antibody responses in COVID-19 patients[J]. The Journal of Biomedical Research, 2020, 34(6): 410-415. DOI: 10.7555/JBR.34.20200134
    [9]Slonim Anthony D., See Helen, Slonim Sheila. Challenges confronting rural hospitals accentuated during COVID-19[J]. The Journal of Biomedical Research, 2020, 34(6): 397-409. DOI: 10.7555/JBR.34.20200112
    [10]Yang Wei. Editorial commentary on special issue of COVID-19 pandemic[J]. The Journal of Biomedical Research, 2020, 34(6): 395-396. DOI: 10.7555/JBR.34.20200701
  • Cited by

    Periodical cited type(5)

    1. Chen B, Julg B, Mohandas S, et al. Viral persistence, reactivation, and mechanisms of long COVID. Elife, 2023, 12: e86015. DOI:10.7554/eLife.86015
    2. Xiao F, Wan P, Wei Q, et al. Prolonged fecal shedding of SARS-CoV-2 in a young immunocompetent COVID-19 patient: A case report and literature overview. J Med Virol, 2022, 94(7): 3133-3137. DOI:10.1002/jmv.27694
    3. Nicholson EG, Avadhanula V, Fragoso S, et al. SARS-CoV-2 re-infection versus prolonged shedding: A case series. Influenza Other Respir Viruses, 2021, 15(6): 691-696. DOI:10.1111/irv.12879
    4. Glans H, Gredmark-Russ S, Olausson M, et al. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses. BMC Infect Dis, 2021, 21(1): 494. DOI:10.1186/s12879-021-06202-8
    5. Ren X, Ren X, Lou J, et al. A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR. EClinicalMedicine, 2021, 34: 100839. DOI:10.1016/j.eclinm.2021.100839

    Other cited types(0)

Catalog

    Article Metrics

    Article views (1681) PDF downloads (132) Cited by(5)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return